It is worthy of note that AFP is a significant influencing factor for delisting liver transplant (LT) candidates with HCC [12] and that identifying HCC candidates at low risk of recurrence seem to be superior to Milan criteria [13], which suggests improved performance by incorporating AFP [14]. The gene discussed is AFP; the disease is hepatocellular carcinoma.